» Authors » Michal Laniado-Schwartzman

Michal Laniado-Schwartzman

Explore the profile of Michal Laniado-Schwartzman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 35
Citations 866
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
21.
Yang L, Quan S, Nasjletti A, Laniado-Schwartzman M, Abraham N
Hypertension . 2004 May; 43(6):1221-6. PMID: 15166181
The heme-heme oxygenase (HO) system has been implicated in the regulation of vascular reactivity and blood pressure. This study examines the notion that overexpression of HO decreases pressor responsiveness to...
22.
Zhang F, Wang M, Wang J, Zand B, Gopal V, Falck J, et al.
Am J Physiol Heart Circ Physiol . 2004 May; 287(3):H1089-95. PMID: 15130884
Cytochrome P-450-4A1 (CYP4A1) is an omega-hydroxylase that catalyzes the metabolism of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE). The goal of this study was to determine the vasomotor consequences of vascular...
23.
Mastyugin V, Mezentsev A, Zhang W, Ashkar S, Dunn M, Laniado-Schwartzman M
J Cell Biochem . 2004 Mar; 91(6):1218-38. PMID: 15048876
Hypoxic injury to the ocular surface provokes an inflammatory response that is mediated, in part, by corneal epithelial-derived 12-hydroxyeicosanoids. Recent studies indicate that a cytochrome P450 (CYP) monooxygenase, identified as...
24.
Ashkar S, Mesentsev A, Zhang W, Mastyugin V, Dunn M, Laniado-Schwartzman M
J Ocul Pharmacol Ther . 2004 Mar; 20(1):65-74. PMID: 15006160
Injury to the ocular surface provokes an inflammatory response that is mediated, at least in part, by corneal epithelial derived 12-hydroxyeicosanoids (HETEs) including 12-HETE and 12-HETrE; both metabolites exhibit potent...
25.
Laffer C, Laniado-Schwartzman M, Nasjletti A, Elijovich F
Hypertension . 2004 Jan; 43(2):388-92. PMID: 14707157
Analogous to observations in Dahl salt-sensitive (SS) rats, we have shown that 20-hydroxyeicosatetraenoic acid (20-HETE) is involved in the pathogenesis of SS essential hypertension. A strong negative correlation between urine...
26.
Jiang M, Mezentsev A, Kemp R, Byun K, Falck J, Miano J, et al.
Circ Res . 2003 Dec; 94(2):167-74. PMID: 14670847
Cytochrome P450 (CYP) 4A1 has been characterized as the most efficient arachidonic acid omega-hydroxylase catalyzing the formation of 20-hydroxyeicosatetraenoic acid (20-HETE), a potent constrictor of the renal and cerebral microcirculation...
27.
Laniado-Schwartzman M, Dunn M
Adv Exp Med Biol . 2003 May; 525:47-54. PMID: 12751735
No abstract available.
28.
Wang M, Wang J, Chang H, Zand B, Jiang M, Nasjletti A, et al.
Am J Physiol Renal Physiol . 2003 Apr; 285(2):F295-302. PMID: 12684227
20-Hydroxyeicosatetraenoic acid (20-HETE), which promotes renal vasoconstriction, is formed in the rat kidney primarily by cytochrome P-450 (CYP) 4A isoforms (4A1, 4A2, 4A3, 4A8). Nitric oxide (NO) has been shown...
29.
Laffer C, Laniado-Schwartzman M, Wang M, Nasjletti A, Elijovich F
Hypertension . 2003 Mar; 41(3 Pt 2):703-8. PMID: 12623983
Cyclooxygenase metabolites of arachidonic acid modulate the natriuretic effect of furosemide. It is not known whether 20-HETE, a monooxygenase metabolite of arachidonic acid that also inhibits sodium transport, participates in...
30.
Laffer C, Laniado-Schwartzman M, Wang M, Nasjletti A, Elijovich F
Circulation . 2003 Feb; 107(4):574-8. PMID: 12566369
Background: Twenty-hydroxyeicosatetraenoic acid (20-HETE) is a cytochrome P450 metabolite of arachidonic acid that produces vasoconstriction and inhibition of renal tubular sodium transport. In Dahl rats, a 20-HETE deficiency plays a...